EMEA Thought Leadership

Articles in the trade press

How patient organizations are advancing healthcare in Africa | March 2024
Source: World Economic Forum
Patient organisations are valuable for policymakers as they understand their community and the challenges they face best. As Africa’s population grows to 2.5 billion by 2050, patient organisations will be essential for all Africans.

 

Boosting healthcare capacity with AI | January 2024
Source: World Economic Forum
Our populations' future health will dramatically change in high-, middle- and low-income countries. Learn how Artificial Intelligence (AI) can help healthcare systems cope with increasing stress and avoid waste in healthcare expenditure.

 

Nine for 2024, Pt 2: Phase change and the challenges of scale | January 2024
Source: Pharmaphorum
The first of two articles on trends in the pharma and life sciences industries to watch out for in 2024. This part examines the trends that will reshape pharmaceutical markets and healthcare provision at scale in 2024 and beyond.

 

Antimicrobial resistance: Avoiding antibiotic overconsumption with the right data | January 2024
Source: World Economic Forum
Antimicrobial resistance, rendering antibiotics ineffective, is incredibly harmful, associated with 4.95 million deaths in 2019. The article discusses how to navigate the complex causes of the AMR challenge, and how to foster innovation of new treatments.

 

Collaborative sustainability by all, for all | January 2024
Source: CPHI Online
CPHI Online has released its 2024 Pharma Trends Outlook report, in which Thought Leadership’s Aurelio Arias contributed to an article on sustainability. The article considers how ESG topics will remain important for pharma in 2024, and discusses the volume of carbon emissions from pharma.

 

Nine for 2024, Pt. 1: From fragility to resilience | December 2023
Source: Pharmaphorum
The first of two articles on trends in the pharma and life sciences industries to watch out for in 2024. This part covers how pharma companies and healthcare systems can address issues of fragility by looking at emerging markets, supply chains, and addressing the healthcare capacity gap.

 

Pro Take: Making Medicines Greener | October 2023
Source: WSJ Sustainable Business
Making and supplying medicines generates roughly a third of the global healthcare industry’s greenhouse-gas emissions. Pharmaceutical companies committed to lowering their carbon footprint say the main challenges arise from their scope 3 emissions. The article covers how pharma companies can reduce their emissions from these sources.

 

Microbiome therapeutics could be the next big thing in pharma | June 2023
Source: Healthcare Brew
The microbiome-based therapeutic market is expected to be worth $1.6 billion by 2026. Interest in this field is growing, especially with two drugs targeting the microbiome being approved in the past year. What is the outlook for the microbiome?

 

Nine for 2023, part one: a reflection on inflection | January 2023
Source: Pharmaphorum
The first in a 3-part series on what trends will be affecting the pharma and life sciences industries in the upcoming year. This first part focuses on global healthcare environmental challenges and what they mean for the pharmaceutical industry.

 

Nine for 2023, part two: healthcare’s hard problem, the prognosis for diagnosis, and key new pharmacotherapy platforms | January 2023
Source: Pharmaphorum
This second part of the 3-part series focuses on opportunities for pharma; the unmet need which lies at the heart of better healthcare provision, Point of Care Diagnostics and new pharmacotherapy classes becoming commercially available in 2023.

 

Nine for 2023, part three: surviving or thriving? | January 2023
Source: Pharmaphorum
This final part of the 3-part series concerns issues that will change the direction of healthcare and the pharmaceutical industry this year, with three key competitive issues for pharmaceutical companies in 2023 being assessed.

 

3 ways healthcare systems can reduce their carbon footprint | November 2022
Source: World Economic Forum
Rapid climate change has a direct impact on human health. The risk to human health bears down heavily upon healthcare systems. What can be done by these systems to reduce their carbon emissions?

 

“Your order has been dispatched”: Moving patient care closer to the home | October 2022
Source: Medhealth Outlook
Healthcare has increasingly moved towards treating patients at an individual level. As part of this phenomena there is a growing focus on providing patients greater flexibility on the location and timing of how they receive care. Learn how pharma and others can success during this change.

 

Is the launch environment really more competitive now? | October 2022
Source: Pharmaphorum
It’s often stated - mostly without reference to data - that the environment for innovative launches is more competitive now than it ever has been. Is this true? We interrogate this claim using IQVIA’s long term market data to analyse nearly 30 years of launches.

 

How can countries achieve digital maturity in healthcare? | August 2022
Source: World Economic Forum
Healthcare systems are becoming increasingly digitised, but this trend has accelerated in the last 10 years, as well as been given a huge boost by the COVID-19 pandemic. Progression towards digital maturity is uneven between countries, but there are successful examples to follow.

 

How clinical development can tackle Africa's unique health needs | May 2022
Source: World Economic Forum
By 2050, the United Nations projects that 25% of all humanity will be African, with non-communicable diseases poised to become the leading cause of deaths in sub-Saharan Africa. The poor level of commercially led clinical development activity in Africa must be addressed considering these changing factors.

Contact Us